Sign in

CIK 0001735438

  • Non-accelerated filer
  • Smaller reporting company

MeiraGTx Holdings plc

Sign in to watch
Ticker
MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
981448305
Phone
+1 646-860-7985
Business address
655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,375,392
in 3 filings, $1.4M under 10b5-1 plans

Net −$1,375,392. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-06-19 Harris Keith R. Director Grant or award · Stock Option (right to buy) +25,000 25,000
2019-06-19 MARCUS JOEL S Director Grant or award · Stock Option (right to buy) +25,000 25,000
2019-05-09 Seligman Nicole Director Grant or award · Stock Option +50,000 50,000
2019-04-01 Gottlieb Bruce General Counsel Grant or award · Stock Option +200,000 200,000
2019-03-01 PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% owner Purchase +1,304,348 $13.80 $18.0M 6,007,746
2019-02-19 Indyk Martin Director Grant or award · Stock Option +50,000 50,000
2018-12-29 Giroux Richard Chief Operating Officer Grant or award · Stock Option +105,000 105,000
2018-12-29 Forbes Alexandria President & CEO Grant or award · Stock Option +130,000 130,000
2018-12-29 Breedis Katherine Chief Financial Officer Grant or award · Stock Option +10,000 10,000
2018-12-29 Naylor Stuart Chief Development Officer Grant or award · Stock Option +100,000 100,000
2018-10-02 Breedis Katherine Chief Financial Officer Grant or award · Stock Option +40,000 40,000
2018-06-12 PERCEPTIVE ADVISORS LLC Director Purchase +1,333,333 $15.00 $20.0M 4,703,398
2018-06-08 PERCEPTIVE ADVISORS LLC Director Purchase +50,000 $15.22 $761K 3,370,065

Page 23 of 23 · 453 trades